Annual Financial Report

RNS Number : 5827Q

Allergy Therapeutics PLC

20 October 2011

 



20 October 2011

Annual Report and Accounts

Allergy Therapeutics Plc (the "Company") announces that pursuant to Rules 20 and 26 of the AIM Rules, the Annual Report and Accounts of the Company for the year ended 30 June 2011 and Notice of Annual General Meeting were posted to shareholders on Monday 17 October 2011.

The Annual Report and Accounts is available on the Company's website at the following address:

http://www.allergytherapeutics.com/Reports%20and%20Presentations%20Sub.aspx

The Notice of Annual General Meeting will shortly be available on the Company's website at the following address:

http://www.allergytherapeutics.com/AGM.aspx

In addition, Resolution 8.2 has been amended as follows: 

The wording "up to an aggregate nominal amount of £31,077,161 being 31,077,161 ordinary shares representing not more than 10% of the issued share capital of the Company" should read "up to an aggregate nominal amount of £31,077.16 being 31,077,161 ordinary shares representing not more than 10% of the issued share capital of the Company". 

It is proposed that at the AGM, which will be held on Wednesday, 16 November 2011, the Chairman will propose that resolution 8.2 be passed with reference to "an aggregate nominal amount of £31,077.16" rather than "an aggregate nominal amount of £31,077,161".

For further information:

Allergy Therapeutics	[phone]
Ian Postlethwaite, Finance Director
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw

 

END

 

 

ACSFEDFWSFFSEES